SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-22-022428
Filing Date
2022-04-29
Accepted
2022-04-28 18:19:27
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ea159041-defa14a_180life.htm DEFA14A 25624
2 GRAPHIC image_001.jpg GRAPHIC 1482
3 GRAPHIC image_002.jpg GRAPHIC 1167
4 GRAPHIC image_003.jpg GRAPHIC 1089
5 GRAPHIC image_004.jpg GRAPHIC 1331
  Complete submission text file 0001213900-22-022428.txt   34216
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38105 | Film No.: 22868771
SIC: 2834 Pharmaceutical Preparations